Nutri Pharma's Vacc-C5 to be prepared for phase I/II clinical trial
Based on encouraging results from pre-clinical research, Nutri Pharma ASA's wholly owned subsidiary Bionor Immuno AS, has announced that it will take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 towards phase I/II clinical trial. Research results to date indic ... more
